WORLDWIDE CONTACT US ABOUT US INVENTING FOR LIFE PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Menu MENU HUMANS FOR HEALTH JOHN HOWE STEPHANIE BARRETT LUIS ZÚÑIGA REBECCA T. RUCK ANGELA JABLONSKI DAN CUA GOKUL SWAMINATHAN JAY SCHILLER HARRIET JOHNSON NOREEN RIZVI PAIGE CRAMER DARIA HAZUDA MICHAEL THIEN GEORGE W. MERCK CHRISTOPHER KISTLER JASON CHEUNG PAUL REICHERT SPENCER DREHER DAISY RICHARDSON Name: Paige Cramer, Ph.D. Title: Associate Director of Global/U.S. Marketing in the neuroscience franchise Education: B.S., Tufts University; Case Western Reserve University, Ph.D. Favorite Downtime Activity: Avid sports enthusiast; being outdoors Paige Cramer 11/19 The people I work with have become my family. There's a strong sense of camaraderie, especially within Merck and our neuroscience department. We are a very strong and motivated group of people who are really trying to better the world.” Paige Cramer, Ph.D. In 2012, Dr. Paige Cramer, along with her team at the Case Western Reserve University in Cleveland, made waves in the scientific community which helped land her on Forbes “30 under 30” list (an honor she’s received twice). And now, after spending four years in Merck’s labs researching neurodegenerative diseases, Paige has a new career adventure on the horizon– this time out of the labs and into our Global Human Health division, the sales and marketing organization for Merck's prescription medicines and vaccines. As an associate director in the Global/U.S. Marketing Department, Paige is putting away the microscope and will pick up a keyboard as she helps communicate to a worldwide audience about our neuroscience research and work. “It's a huge opportunity,” she says about the move. “My new role will expand my experience within the neuroscience department while giving me the chance to tackle new and different challenges. And, in the end, I’ll still be able to contribute to my initial mission of delivering new treatment options to patients.” The transition is one Paige has always wanted, saying when she initially started at Merck she wanted to stay in the labs only a few years and then “see what else is possible.” Focus on Talent Development This kind of talent development is important at Merck. We believe in helping our employees understand all aspects of our business. This means supporting our workers as they branch out into other areas and departments to learn all they can about how we operate. Career development and flexible career paths are a priority for Merck because we believe that bringing together a diversity of backgrounds, ideas and approaches makes our company stronger. “Merck recruits top talent. The people I’ve worked with so far are amazing collaborators and peer leaders. It’s a great place to come to work,” she says, saying that when she initially moved to the Philadelphia region from the Midwest (Ohio), she didn’t know anyone in the area. That quickly changed once she started. “The people I work with have become my family. There's a strong sense of camaraderie, especially within Merck and our neuroscience department. We are a very strong and motivated group of people who are really trying to better the world.” Millennial Moves Paige is so invested in Merck, she helped launch the Merck Network for Millennials, a group that focuses on delivering cultural and generational insights across our business and helping all Merck employees connect with the Millennial Generation (those born after 1980 and the first generation to come of age in the new millennium). “[The group] is still in its infancy, but it's gaining momentum,” she says. “The network is growing and bringing out a lot of great ideas and creative energy. I hope we are proving to be a valuable resource for all employees. As I’ve experienced firsthand, Merck really invests in developing and retaining its employees. The Merck Network for Millennials is just one example of the company’s commitment to understanding and appreciating the differences between generations.” Name: Paige Cramer, Ph.D. Title: Associate Director of Global/U.S. Marketing in the neuroscience franchise Education: B.S., Tufts University; Case Western Reserve University, Ph.D. Favorite Downtime Activity: Avid sports enthusiast; being outdoors Interested in joining in our mission to save and improve lives? Start your job search! Published Sept. 2016 Copyright. © 2009-2018 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map ×Close FORWARD-LOOKING STATEMENT FORWARD-LOOKING STATEMENT OF MERCK & CO., INC., KENILWORTH, NJ, USA This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). NO DUTY TO UPDATE The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date. x Worldwide MERCK Canada United States MSD Merck is known as MSD outside the United States and Canada. Clicking on any of the links below will take you to a website intended for those living outside the United States and Canada. Algeria – French Argentina – Spanish Australia – English Austria – German Belgium – Dutch, French, English Brazil – Portuguese Bulgaria – Bulgarian Caribbean – English Central America – Spanish Chile – Spanish China – Simplified Chinese Colombia – Spanish Costa Rica – Spanish Croatia – Croatian Czech Republic – Czech Denmark – Danish Dominican Republic – Dominican Ecuador – Spanish Egypt – English Estonia – Estonian Finland – Finnish France – French Fulford India – English Germany – German Greece – Greek Hong Kong – Chinese, English Hungary – Hungarian India – English Indonesia – English Ireland – English Italy – Italian Japan – Japanese Latvia – Latvian Lithuania – Lithuanian Malaysia – English Mexico – Spanish Montenegro – Serbian Netherlands – Dutch New Zealand – English Norway – Norwegian Peru – Spanish Philippines – English Poland – Polish Portugal – Portuguese Puerto Rico – Spanish, English Romania – Romanian, English Russia – Russian Saudi Arabia – English Serbia – Serbian Singapore – English Slovakia – Slovak Slovenia – Slovene South Africa – English South Korea – Korean Spain – Spanish Sweden – Swedish Switzerland – English, French, German Taiwan – Traditional Chinese Thailand – Thai, English Turkey – Turkish Ukraine – Ukrainian United Kingdom – English Venezuela – Spanish Vietnam – Vietnamese Close